Background/Aims: Non-esterified fatty acids (NEFAs) are important inducers of inflammatory responses and hepatic lipid accumulation, which lead to non-alcoholic fatty liver disease (NAFLD). High plasma NEFA is found in NAFLD patients, and associated with metabolic syndrome and type-2 diabetes. NFκB is known to upregulate Orai1, the Ca 2+ channel responsible for storeoperated Ca 2+ entry. The present study explored the role of NEFA-sensitive NFκB-dependent Orai1 expression in the regulation of lipid synthesis. Methods: BRL-3A rat liver hepatocyte lines were studied in the absence and presence of NEFA. Transcript and protein expression levels of factors involved in lipid synthesis were quantified by quantitative polymerase chain reaction (qPCR) and western blot analyses. Fatty acids were measured by immunofluorescence. Results: NEFA significantly increased, as indicated by the expression of sterol regulatory element-binding protein 1 (SREBP-1c), fatty acid synthase (FAS), acetyl-CoA carboxylase α (ACC1), Orai1, and NFκB p65 by qPCR and western blot analyses. These effects were reversed by the Orai1 inhibitor, 2-aminoethoxydiphenyl borate, and the NFκB inhibitor, wogonin. Furthermore, SREBP-1c, FAS, ACC1, and Orai1 were significantly decreased by Orai1 silencing. Conclusions: Taken together, these results demonstrated that NEFA-sensitive NFκB-dependent Orai1 expression regulates de novo lipogenesis.
Introduction
Non-alcoholic fatty liver disease (NAFLD) is a very common disorder characterized by excessive lipid deposition in hepatocytes (steatosis) with no alcohol consumption [1] . NAFLD contributes significantly to morbidity and mortality associated with obesity, type 2 diabetes, and metabolic syndrome [2, 3] . NAFLD involves increased hepatic fatty acid synthesis, decreased fatty acid catabolism [4] , and cellular stress, including oxidative stress [5] , inflammatory/immune responses, and endoplasmic reticulum stress [6] .
Normally, non-esterified fatty acids (NEFAs) and triglycerides (TGs) are increased in the plasma of NAFLD patients. The major NEFAs include palmitic, palmitoleic, stearate, oleic, and linoleic acids [7] [8] [9] . Previous studies have reported that single fatty acids can influence lipid accumulation. In the present study, a high concentration of NEFAs was prepared to approximate the composition and concentration of circulating NEFAs. Fatty acids in the liver used for TG synthesis are provided by the diet, adipose tissue lipolysis, or de novo lipogenesis [10] . Previous reports indicate that sterol regulatory element-binding protein 1 (SREBP-1c), acetyl-CoA carboxylase α (ACC1), and fatty acid synthase (FAS) were important factors in de novo lipogenesis [11] [12] [13] . However, the mechanisms underlying the regulation of lipid metabolic pathways in the setting of NAFLD have only been partially elucidated. Recent observations showed that lipid accumulation in chronic obesity is stimulated by cytosolic Ca 2+ concentrations ([Ca   2+ ] i ) in the livers of Zucker rats, and that store-operated calcium entry (SOCE) was involved in regulating metabolism [14] [15] [16] . A better understanding of the regulation of lipid metabolism in steatotic hepatocytes will provide insight that could lead to the development of new therapeutic strategies for the control of NAFLD.
To the best of our knowledge, the role of the cytosolic [Ca 2+ ] i in lipid accumulation of NAFLD, especially in de novo lipogenesis, remains unknown. In some cell types, Ca 2+ may enter through SOCE, which is accomplished by the 4-transmembrane-spanning pore forming calcium release-activated channel moiety Orai1 [17] [18] [19] . Orai1 has previously been shown to be regulated by nuclear factor NFκB [20, 21] .
In patients with NAFLD and type 2 diabetes, excessive amounts of TGs are deposited in hepatocytes leading to steatosis and the activation of the NFκB pathway [22] . The present study explored whether NEFA induces de novo lipogenesis on BRL-3A cells and, if so, whether the effect involves NFκB-sensitive Orai1 expression.
Materials and Methods
Cell culture BRL-3A rat liver cells were cultured in high-glucose Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum and 1% penicillin/streptomycin under standard culture conditions. Cells were pretreated with 1.2 mM NEFA preparation for 6 h after starvation overnight. Then, 50 μM Orai1 inhibitor, 2-APB (Tocris Bioscience, Bristol, UK), or 100 µM NFκB inhibitor, wogonin (Sigma-Aldrich Corporation, St. Louis, MO, USA), were added for 6 h.
NEFA preparation
The composition and concentration of NEFAs used in this study were chosen to approximate the concentrations of serum NEFAs [23] [24] [25] . The stock NEFA (10 mM) solution included oleic acid (4.35 mM), linoleic acid (0.49 mM), palmitic acid (3.19 mM), stearic acid (1.44 mM), and palmitoleic acid (0.53 mM). Stock NEFA solution was diluted in cell culture medium to achieve a final total NEFA concentration of 1.2 mM.
RNA Silencing
For silencing, 3 x 10 5 cells (6-well plate) were seeded 24 h before the experiment and then transfected with 40 pM rat Orai1 siRNA (Shanghai GenePharma Co., Ltd., Shanghai, China) or non-targeting siRNA (Shanghai GenePharma Co., Ltd.) using siRNA-Mate transfection reagent (Shanghai GenePharma Co., Ltd.) according to the manufacturer's protocol.
Quantification of mRNA expression
Total RNA was isolated with Trizol RNA extraction reagent (Invitrogen Corporation, Carlsbad, CA, USA); mRNA was transcribed with Reverse Transcriptase M-MLV (RNase H-) (Takara Bio, Inc., Otsu, Japan) using an oligodT primer. Quantitative RT-PCR was performed on a BioRad iCycler iQTM Real-Time PCR Detection System (Bio-Rad Laboratories Inc., Hercules, CA, USA).
The 
Western blot analysis
Orai1, NFκB p65, SREBP-1c, FAS and ACC1 relative protein abundances were determined in BRL-3A rat liver cells. The cells were washed in ice-cold PBS. RIPA lysis buffer (Beyotime Biotechnology, Shanghai, China) was added to solubilize the cells. Samples were incubated on ice for 30 min and then centrifuged at 14, 000 rpm and 4°C for 20 min. The supernatant was removed and used for Western blotting. Total protein (40-60 µg) was separated by SDS-PAGE, thereafter transferred to PVDF membranes and blocked in 5% non-fat milk/Tris-buffered saline/Tween-20 (TBST) at room temperature for 1 hour. Membranes were probed overnight at 4ºC with polyclonal rabbit or mouse antibodies against Orai1, SREBP-1c, ACC1, FAS, or NFκB p65 (1:700 to 1:1000 in TBS containing 5% BSA and Tween 20). After incubation with HRPlabeled goat anti-rabbit or mouse secondary antibody (Beyotime Biotechnology, 1:2000) for 1 hour at room temperature, bands were visualized with enhanced chemiluminescence reagents (Beyotime). Membranes were also probed with β-Actin antibody (Cell signaling, 1:2000) as loading control. Densitometric analyses were performed using Image J software.
TG content assay After treatments, the cells were collected. The TG content in BRL-3A cells was determined using an enzymatic method with the TG assay kit (Applygen Technologies Inc., Beijing, China) in accordance with the manufacturer's instructions.
Lipid droplet fluorescence assay BRL-3A cells were treated with 1.2 mM NEFA for 6, 9, or 12 h for assessment of lipid droplet fluorescence by cellular staining with BODIPY 493/503 (Invitrogen Corporation) according to the manufacturer's instructions. Coverslips were mounted with glycerinum and images were obtained with a confocal laserscanning microscope (Leica TCS SP8; Leica, Wetzlar, Germany) with 40×/1.3 NA differential interference contrast and analyzed with the instrument's software.
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Statistical analysis
Data are presented as the means ± standard error of the mean (SEM) with n representing the number of independent experiments. All data were tested for significance with the unpaired Student's t-test or oneway analysis of variance (ANOVA) followed by the Tukey post-hoc test. A probability (p) value of < 0.05 was considered statistically significant.
Results
The present study explored hepatocyte de novo lipogenesis in the presence of high concentrations of NEFA and the involvement of NFκB and Orai1 in this process.
We first investigated the effect of high-concentration NEFA on lipid accumulation and secretion in BRL-3A cells. As illustrated in Figs. 1A and 1B, incubation with 1.2 mM NEFA for 12 h caused extensive lipid droplet formation and increased TG synthesis (Fig. 1C) .
The next series of experiments explored whether SOCE via Orai1 and NFκB p65 are induced in BRL-3A cells in response to NEFA, and therefore may participate in the regulation of de novo lipogenesis. As illustrated in Fig. 2 , expressions of mRNA and protein of Orai1 and NFκB p65 were dramatically up-regulated by NEFA treatment and these effects were reduced by the Orai1 inhibitor, 2APB, and the NFκB inhibitor, wogonin. Moreover, transcription levels of SREBP-1c, ACC1, and FAS were significantly reduced by both 2APB and wogonin, respectively (Fig. 3A) . As illustrated in Figs. 3B and 3C, mRNA and protein levels of de novo lipogenesis were significantly decreased by siOai1. To verify the silencing efficiency, Orai1 transcript and protein levels were quantified, which showed that both were dramatically decreased in cells transfected with siOrai1. Furthermore, mRNA and protein levels of de novo lipogenesis were significantly increased by the Ca 2+ ionophore ionomycin (Figs. 3D and 3E ) Finally, we determined whether SOCE and/or NFκB are required for lipid accumulation in the presence of high NEFA concentrations. Since Orai1 entry into BRL-3A cells could be attenuated by the NFκB inhibitor wogonin, we tested whether de novo lipogenesis was also NFκB-sensitive. Indeed, the transcript and protein levels of SREBP-1c, ACC1, and FAS were reduced by the NFκB inhibitor wogonin and the Orai1 inhibitor 2APB (Fig. 4) .
Discussion
The present observations disclose a decisive role of NFκB-Orai1 on de novo lipogenesis. The results showed that high concentrations of NEFA promoted de novo lipogenesis, which resulted in abnormal hepatic lipid accumulation. According to the present observations, the transcript and protein expression levels of SREBP-1c, ACC1, and FAS were dramatically increased by NEFA Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry treatment during starvation. These effects were virtually abrogated by the inhibition of NFκB and Orai1. The present observations do not rule out involvement of further signals triggered by the NFκB-Orai1 pathway. The regulation of de novo lipogenesis by NFκB-Orai1 is expected to influence cellular ionic metabolism. The present study also showed that transcript and protein expression levels of SREBP-1c, ACC1, and FAS were significantly increased by ionomycin, but decreased by siOrai1, indicating that Orai1 may contribute to de novo lipogenesis by promoting the transfer of NFκB p65, which results in the release of pro-inflammatory factors and subsequent induction of liver injury. Indeed, saturated fatty acids can activate the NFκB pathway. Moreover, oleic acid or starvation can induce SOCE and maintain a sustained elevation in intracellular Ca 2+ levels [16, 26] . SREBP-1c, a membrane-bound transcription factor, promotes TG secretion and lipid droplet formation by stimulating expression of genes involved in fatty acids synthesis. FAS is an important enzyme involved in the de novo synthesis of long-chain fatty acids by converting the acetyl-CoA into palmitate, which is subsequently esterified into TGs in the liver. When energy is available, hepatic fatty acids are esterified into glycerol and stored as triacylglycerol or secreted as very low-density lipoproteins. ACC, the rate-limiting enzyme that catalyzes the carboxylation of acetyl-CoA to form malonyl-CoA, is the pivotal enzyme in the biosynthesis of long-chain fatty acids [27] . Previous studies have shown that dietary fat causes synthesis of hepatic fatty acid synthesis, including SREBP-1c, ACC1, and FAS [28] . Moreover, the impairment of lipid metabolism via the inflammatory signaling of toll-like receptor 4 and NFκB has been reported in high fat diet-induced NAFLD [29] . High concentration NEFA causes several inflammatorybased diseases, such as cardiovascular disease, diabetes, and NAFLD by regulating de novo lipogenesis [30, 31] . In view of the present observations, it is tempting to speculate that the remarkable increase in de novo lipogenesis by high dietary fat or starvation results from NFκB-dependent SOCE via Orai1. 
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Plasma NEFA, as the major source of fatty acids for TG synthesis, causes abnormal lipid accumulation, which leads to the development of NAFLD [32, 33] . In the present study, the content of TG was measured with an enzyme-linked immunosorbent assay, which indicated that NEFA stimulated TG synthesis and secretion or insulin resistance, resulting in the accumulation of TG. Hence, the NFκB-Orai1 pathway may contribute to TG accumulation.
In conclusion, the present study demonstrated for the first time the involvement of NEFAsensitive NFκB-Orai1 signaling in the regulation of de novo lipogenesis in BRL-3A cells, which included SREBP-1c, FAS, and ACC1.
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